EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs

Hannah Solchenberger iD, Marcus Odendahl iD, Dirk Schriefer iD, Undine Proschmann, Georges Katoul Al Rahbani, Tjalf Ziemssen iD, Katja Akgün iD

Pathogens · 2025

DOI: 10.3390/pathogens14030235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Hannah Solchenberger und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center of Clinical Neuroscience, Department of Neurology, Carl Gustav Carus University Hospital, Technical University Dresden, 01307 Dresden, Germany. Hauptthemen laut MEDLINE: Multiple Sclerosis, SARS-CoV-2, COVID-19, COVID-19 Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Technical University of Dresden, Gemeinnuetzige Hertie Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disease-modifying therapies (DMTs) are known to impact cellular and humoral immune response in persons with multiple sclerosis (pwMS). In this study, we performed in-depth SARS-CoV-2-specific T-cell profiling using flow cytometry. T-cell immunity in pwMS with or without DMTs was evaluated before a first SARS-CoV-2 messenger ribonucleic acid (mRNA) vaccination and at one-, two- and six-month follow-up. T-cell stimulation without SARS-CoV-2-specific antigens was used as a control. T-cell response was compared to B-cell response by evaluating SARS-CoV-2-specific antibodies. We observed an upregulation of specific subpopulations of SARS-CoV-2 spike-specific CD4+ T cells. Thus, our results demonstrate the induction of a broad and distinct CD4+ T-cell response in pwMS even on anti-CD20 treatment and sphingosine-1-phosphate receptor modulation after SARS-CoV-2 mRNA vaccination. This was particularly seen in CD4+high and CD4+CD154+ T cells. Our results do not support the induction of a CD8+ T-cell immune response. While humoral immune response was impaired in pwMS during ocrelizumab and fingolimod treatment, there was evidence of a compensatory upregulation of subpopulations of SARS-CoV-2-specific CD4+ T cells at low levels of seroconversion in pwMS. In conclusion, our results provide important insights into the mechanisms of the adaptive immune response in pwMS following SARS-CoV-2 mRNA vaccination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisSARS-CoV-2COVID-19COVID-19 VaccinesT-LymphocytesHumansAdultFemaleMaleMiddle AgedCD4-Positive T-LymphocytesAntibodies, ViralVaccinationFingolimod HydrochlorideB-LymphocytesImmunosuppressive Agents

Stichwörter der Autor:innen

SARS-CoV-2T-cell profilinganti-CD20 treatmentdisease-modifying therapymRNA vaccinesmultiple sclerosissphingosine-1-phosphate receptor modulation

Substanzen

COVID-19 VaccinesAntibodies, ViralFingolimod HydrochlorideImmunosuppressive Agents

Autor:innen und Institutionen

  • Center of Clinical Neuroscience, Department of Neurology, Carl Gustav Carus University Hospital, Technical University Dresden, 01307 Dresden, Germany.
  • Medical Faculty Carl Gustav Carus, Technical University Dresden, Experimental Transfusion Medicine, 01307 Dresden, Germany.
  • Institute for Transfusion Medicine Dresden, German Red Cross Blood Donation Service North-East, 01307 Dresden, Germany.

ORCID-Profile: Hannah Solchenberger, Marcus Odendahl, Dirk Schriefer, Tjalf Ziemssen, Katja Akgün

Förderung

  • Technical University of Dresden
  • Gemeinnuetzige Hertie Stiftung

Zitieren

APA

Solchenberger, H., Odendahl, M., Schriefer, D., Proschmann, U., Rahbani, G. K. A., Ziemssen, T., & Akgün, K. (2025). Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs. Pathogens. https://doi.org/10.3390/pathogens14030235

Vancouver

Solchenberger H, Odendahl M, Schriefer D, Proschmann U, Rahbani GKA, Ziemssen T, et al. Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs. Pathogens. 2025. doi:10.3390/pathogens14030235

BibTeX
@article{Solchenberger2025,
  author = {Solchenberger, Hannah and Odendahl, Marcus and Schriefer, Dirk and Proschmann, Undine and Rahbani, Georges Katoul Al and Ziemssen, Tjalf and Akgün, Katja},
  title = {Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14030235}
}
Kostenlos starten →